These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome. Rueda N; Flórez J; Martínez-Cué C Neurosci Lett; 2008 Mar; 433(1):22-7. PubMed ID: 18226451 [TBL] [Abstract][Full Text] [Related]
10. Sustained treatment with an α5 GABA A receptor negative allosteric modulator delays excitatory circuit development while maintaining GABAergic neurotransmission. Nuwer JL; Brady ML; Povysheva NV; Coyne A; Jacob TC Neuropharmacology; 2021 Oct; 197():108724. PubMed ID: 34284042 [TBL] [Abstract][Full Text] [Related]
15. Behavioural pharmacology of the α5-GABA Gacsályi I; Móricz K; Gigler G; Wellmann J; Nagy K; Ling I; Barkóczy J; Haller J; Lambert JJ; Szénási G; Spedding M; Antoni FA Neuropharmacology; 2017 Oct; 125():30-38. PubMed ID: 28694097 [TBL] [Abstract][Full Text] [Related]
16. Long-lasting correction of in vivo LTP and cognitive deficits of mice modelling Down syndrome with an α5-selective GABA Duchon A; Gruart A; Albac C; Delatour B; Zorrilla de San Martin J; Delgado-García JM; Hérault Y; Potier MC Br J Pharmacol; 2020 Mar; 177(5):1106-1118. PubMed ID: 31652355 [TBL] [Abstract][Full Text] [Related]
17. Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABA(A) alpha5 inverse agonist series. Achermann G; Ballard TM; Blasco F; Broutin PE; Büttelmann B; Fischer H; Graf M; Hernandez MC; Hilty P; Knoflach F; Koblet A; Knust H; Kurt A; Martin JR; Masciadri R; Porter RH; Stadler H; Thomas AW; Trube G; Wichmann J Bioorg Med Chem Lett; 2009 Oct; 19(19):5746-52. PubMed ID: 19726184 [TBL] [Abstract][Full Text] [Related]
18. Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists. Kleschevnikov AM; Belichenko PV; Faizi M; Jacobs LF; Htun K; Shamloo M; Mobley WC J Neurosci; 2012 Jul; 32(27):9217-27. PubMed ID: 22764230 [TBL] [Abstract][Full Text] [Related]
19. Short-term memory impairment after isoflurane in mice is prevented by the α5 γ-aminobutyric acid type A receptor inverse agonist L-655,708. Saab BJ; Maclean AJ; Kanisek M; Zurek AA; Martin LJ; Roder JC; Orser BA Anesthesiology; 2010 Nov; 113(5):1061-71. PubMed ID: 20966663 [TBL] [Abstract][Full Text] [Related]